<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULES 13D-1 (b) AND (c)
AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(Amendment No. 2)*
BioTransplant Incorporated
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
09066Y107
-------------------
(CUSIP Number)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 21 Pages
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 2 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Ventures II, L.P
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 1,570,886
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,570,886
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,570,886
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 3 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Partners II, L.P
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 1,570,886
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,570,886
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,570,886
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 4 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Ventures III, L.P
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 874,539
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
874,539
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
874,539
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
10.2%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 5 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Partners III, L.P
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 874,539
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
874,539
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
874,539
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
10.2%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 6 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Ventures IV, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 258,075
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
258,075
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
258,075
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
3.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 7 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Partners IV, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 258,075
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
258,075
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
258,075
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
3.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 8 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
James H. Cavanaugh, Ph.D.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,703,500
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,703,500
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,703,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
31.5%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 9 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Harold R. Werner
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,703,500
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,703,500
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,703,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
31.5%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 10 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William Crouse
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
15,625
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,703,500
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
15,625
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,703,500
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,719,125
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
32.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------------- -----------------------------
CUSIP NO. 09066Y107 13G Page 11 of 21 Pages
- ------------------------------- -----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
John W. Littlechild
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,703,500
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,703,500
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,703,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
31.5%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 12 of 21
Item 1.
(a) Name of Issuer:
BioTransplant Incorporated
(b) Address of Issuer's Principal Executive Offices:
Charlestown Navy Yard, Building 75, Third Avenue
Charlestown, Massachusetts 02129
Item 2.
(a) Name of Person Filing:
HealthCare Ventures II, L.P. ("HCV II"), HealthCare Partners
II, L.P. ("HCP II"), HealthCare Ventures III, L.P. ("HCV
III"), HealthCare Partners III, L.P. ("HCP III"), HealthCare
Ventures IV, L.P. ("HCV IV"), HealthCare Partners IV, L.P.
("HCP IV"), Dr. Cavanaugh and Messrs. Werner, Littlechild and
Crouse(1). See attached Exhibit A which is a copy of their
agreement in writing to file this statement on behalf of each
of them.(2)
(b) Address of Principal Business Office or, if none, Residence:
The business address for HCV II, HCP II, HCV III, HCP III, HCV
IV, HCP IV and Dr. Cavanaugh and Messrs. Werner and Crouse is
44 Nassau Street, Princeton, New Jersey 08542. The business
address for Mr. Littlechild is One Kendall Square, Building
300, Cambridge, Massachusetts 02139.
(c) Citizenship:
HCV II, HCP II, HCV III, HCP III, HCV IV and HCP IV are
limited partnerships organized under the laws of the State of
Delaware. Dr. Cavanaugh and Messrs. Werner, Littlechild and
Crouse are each United States citizens.
- ------------------------------
(1) Mr. Leschly withdrew as a general partner of each of HCP III
and HCP IV effective July 1, 1999.
(2) Dr. Cavanaugh and Messrs. Werner, Littlechild and Crouse are
general partners of HCP II, HCP III and HCP IV, the general
partner of each of HCV II, HCV III and HCV IV, respectively,
the record holder of Issuer's securities.
<PAGE>
Page 13 of 21
(d) Title of Class of Securities:
Common Stock, par value $.01 ("Shares").
(e) CUSIP Number:
09066Y107
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
Inapplicable.
Item 4. Ownership.
(a) Amount Beneficially Owned:
As of December 31, 1999: HCV II and HCP II beneficially owned
1,570,886 Shares of Issuer's Securities, consisting of
1,492,009 Shares of Issuer's Common Stock and immediately
exercisable warrants to purchase 78,877 Shares of Issuers
Common Stock; HCV III and HCP III beneficially owned 874,539
Shares of Issuer's Securities, consisting of 774,834 Shares of
Issuer's Common Stock and immediately exercisable warrants to
purchase 99,705 Shares of Issuer's Common Stock; HCV IV and
HCP IV beneficially owned 258,075 Shares of Issuer's
Securities, consisting of 228,504 Shares of Issuer's Common
Stock and immediately exercisable warrants to purchase 29,571
Shares of Issuer's Common Stock; Dr. Cavanaugh and Messrs.
Werner and Littlechild beneficially owned 2,703,500 Shares of
Issuer's Securities, consisting of 2,495,347 Shares of Common
Stock and immediately exercisable warrants to purchase 208,153
Shares of Issuer's Common Stock; and Mr. Crouse beneficially
owned 2,719,125 Shares of Issuer's Securities, consisting of
2,495,972 Shares of Issuer's Common Stock and immediately
exercisable warrants and options to purchase 223,153 Shares of
Issuer's Common Stock.
(b) Percent of Class:
As of December 31, 1999: the 1,570,886 Shares of Issuer's
Securities beneficially owned by HCV II and HCP II constitute
18.3% of Issuer's Shares outstanding; the 874,539 Shares of
Issuer's Securities beneficially owned by HCV III and HCP III
constitute 10.2% of the Issuer's Shares outstanding; the
258,075 Shares of Issuer's Securities beneficially owned by
HCV IV and HCP IV constitute 3.0% of Issuer's Shares
outstanding; the 2,703,500 Shares of Issuer's Securities
beneficially owned by Dr. Cavanaugh and Messrs. Werner and
Littlechild constitute 31.5% of Issuer's Shares outstanding;
and the 2,719,125 Shares of Issuer's Securities beneficially
owned by Mr. Crouse constitute 32.0% of Issuer's Shares
outstanding.
<PAGE>
Page 14 of 21
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Inapplicable
(ii) shared power to vote or to direct the vote: HCV II,
HCP II, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to vote or direct the vote
of those Shares owned by HCV II.
HCV III, HCP III, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to vote or
direct the vote of those Shares owned by HCV III.
HCV IV, HCP IV, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to vote or
direct the vote of those Shares owned by HCV IV.
(iii) sole power to dispose or to direct the disposition
of:
Inapplicable
(iv) shared power to dispose of or to direct the
disposition of: HCV II, HCP II, Dr. Cavanaugh and
Messrs. Werner, Littlechild and Crouse share the
power to dispose of or direct the disposition of
those Shares owned by HCV II.
HCV III, HCP III, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to dispose of
or direct the disposition of those Shares owned by
HCV III.
HCV IV, HCP IV, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to dispose of
or direct the disposition of those Shares owned by
HCV IV.
Item 5. Ownership of Five Percent or less of a Class:
Inapplicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Inapplicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company:
<PAGE>
Page 15 of 21
Inapplicable.
Item 8. Identification and Classification of Members of the Group:
Inapplicable.
Item 9. Notice of Dissolution of Group:
Inapplicable.
Item 10. Certification:
Inapplicable.
<PAGE>
Page 16 of 21
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
<TABLE>
<S> <C>
Dated: February 11, 2000 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners II, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners II, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners III, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners III, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners IV, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners IV, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
James H. Cavanaugh, Ph.D.
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
Harold R. Werner
</TABLE>
<PAGE>
Page 17 of 21
<TABLE>
<S> <C>
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Cambridge, Massachusetts -----------------------------
John W. Littlechild
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
William Crouse
</TABLE>
<PAGE>
Page 18 of 21
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with
regulatory authorities a Schedule 13G and any future amendments thereto
reporting each of the undersigned's ownership of securities of BioTransplant
Incorporated and hereby affirm that such Schedule 13G is being filed on behalf
of each of the undersigned.
<TABLE>
<S> <C>
Dated: February 11, 2000 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners II, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners II, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners III, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners III, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners IV, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners IV, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
James H. Cavanaugh, Ph.D.
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
Harold R. Werner
</TABLE>
<PAGE>
Page 19 of 21
<TABLE>
<S> <C>
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Cambridge, Massachusetts -----------------------------
John W. Littlechild
Dated: February 11, 2000 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
William Crouse
</TABLE>
<PAGE>
Page 20 of 21
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
<TABLE>
<S> <C>
Dated: February 11, 2000 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners II, L.P.
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners II, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners III, L.P.
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners III, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners IV, L.P.
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners IV, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
James H. Cavanaugh, Ph.D.
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
Harold R. Werner
Dated: February 11, 2000 By:
Cambridge, Massachusetts -------------------------------
John W. Littlechild
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
William Crouse
</TABLE>
<PAGE>
Page 21 of 21
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with
regulatory authorities a Schedule 13G and any future amendments thereto
reporting each of the undersigned's ownership of securities of BioTransplant
Incorporated and hereby affirm that such Schedule 13G is being filed on behalf
of each of the undersigned.
<TABLE>
<S> <C>
Dated: February 11, 2000 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners II, L.P.
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners II, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners III, L.P.
By: -------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners III, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner, HealthCare Partners IV, L.P.
By:
-------------------------------
A General Partner
Dated: February 11, 2000 HealthCare Partners IV, L.P.
Princeton, New Jersey
By:
-------------------------------
A General Partner
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
James H. Cavanaugh, Ph.D.
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
Harold R. Werner
Dated: February 11, 2000 By:
Cambridge, Massachusetts -------------------------------
John W. Littlechild
Dated: February 11, 2000 By:
Princeton, New Jersey -------------------------------
William Crouse
</TABLE>
